GIM
PRVA icon

Glenmede Investment Management’s Privia Health PRVA Stock Holding History

Glenmede Investment Management’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.45M Sell
58,076
-37
-0.1% -$796 0.01% 617
2025
Q2 		$1.34M Buy
+58,113
New +$1.35M 0.01% 643

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenmede Investment Management's PRVA Position: Q3 2025 in Review

Glenmede Investment Management reduced its Privia Health (PRVA) stake by 0.06% in Q3 2025, selling an estimated $796 and leaving 58,076 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #617.

Glenmede Investment Management first reported a position in PRVA in Q2 2025 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Glenmede Investment Management held 58,076 shares of Privia Health worth $1.45M as of Q3 2025.
  • Glenmede Investment Management sold 37 Privia Health shares in Q3 2025, an estimated $796.
  • Privia Health made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #617 holding.
  • Glenmede Investment Management first reported a position in Privia Health in Q2 2025 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.